Literature DB >> 19561441

Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia.

Denys T Lau1, Nathaniel D Mercaldo, Andrew T Harris, Emily Trittschuh, Joseph Shega, Sandra Weintraub.   

Abstract

This cross-sectional study examines the association between total prescription medication use and potentially inappropriate medication use (PIRx) among community-dwelling elderly patients with and without dementia. Data (September 2005 to September 2007) were from the National Institute on Aging-funded National Alzheimer's Coordinating Center Uniform Data Set. The study analyzed the Uniform Data Set initial visits of 4518 community-dwelling subjects aged 65 years and above with and without dementia (2665 and 1853, respectively). PIRx was defined using a partial list of the 2003 Beers criteria. Generalized linear mixed models were applied to estimate the association between PIRx and polypharmacy. In both groups (with and without dementia), subjects who received PIRx on average took more medications than those taking no PIRx. As the total number of medications used increased, the odds of having PIRx also increased, controlling for dementia diagnosis and other subject characteristics. Our key findings were consistent after considering 2 definitions of PIRx (with or without oral estrogens) and accounting for missing data. In summary, the total number of medications used is associated with PIRx among Alzheimer's Disease Centers community-dwelling elderly patients with and without dementia, with polypharmacy increasing the risk of PIRx. Ensuring appropriate medication use in this population is clinically important because of the significant risks for institutionalization.

Entities:  

Mesh:

Year:  2010        PMID: 19561441      PMCID: PMC2837122          DOI: 10.1097/WAD.0b013e31819d6ec9

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  24 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

2.  Potential pitfalls of disease-specific guidelines for patients with multiple conditions.

Authors:  Mary E Tinetti; Sidney T Bogardus; Joseph V Agostini
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

Review 3.  Health outcomes and polypharmacy in elderly individuals: an integrated literature review.

Authors:  Susan C Frazier
Journal:  J Gerontol Nurs       Date:  2005-09       Impact factor: 1.254

4.  Polypharmacy and falls in the middle age and elderly population.

Authors:  G Ziere; J P Dieleman; A Hofman; H A P Pols; T J M van der Cammen; B H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

5.  Potentially inappropriate medication use among elderly home care patients in Europe.

Authors:  Daniela Fialová; Eva Topinková; Giovanni Gambassi; Harriet Finne-Soveri; Pálmi V Jónsson; Iain Carpenter; Marianne Schroll; Graziano Onder; Liv Wergeland Sørbye; Cordula Wagner; Jindra Reissigová; Roberto Bernabei
Journal:  JAMA       Date:  2005-03-16       Impact factor: 56.272

Review 6.  Inappropriate prescribing for the elderly: beers criteria-based review.

Authors:  R R Aparasu; J R Mort
Journal:  Ann Pharmacother       Date:  2000-03       Impact factor: 3.154

7.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

Authors:  D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

Review 8.  Pharmacological treatment of Alzheimer's Disease.

Authors:  Angelo Bianchetti; Piera Ranieri; Alessandro Margiotta; Marco Trabucchi
Journal:  Aging Clin Exp Res       Date:  2006-04       Impact factor: 3.636

9.  The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use.

Authors:  Julie P W Bynum; Peter V Rabins; Wendy Weller; Marlene Niefeld; Gerard F Anderson; Albert W Wu
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  60 in total

1.  The impact of family caregivers on potentially inappropriate medication use in noninstitutionalized older adults with dementia.

Authors:  Joshua M Thorpe; Carolyn T Thorpe; Korey A Kennelty; Walid F Gellad; Richard Schulz
Journal:  Am J Geriatr Pharmacother       Date:  2012-06-09

Review 2.  Routine deprescribing of chronic medications to combat polypharmacy.

Authors:  Doron Garfinkel; Birkan Ilhan; Gulistan Bahat
Journal:  Ther Adv Drug Saf       Date:  2015-12

3.  Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea.

Authors:  Hae-Young Park; Ji-Won Park; Hyun Soon Sohn; Jin-Won Kwon
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

4.  Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions.

Authors:  Ariel R Green; Patricia Lee; Emily Reeve; Jennifer L Wolff; Chi Chiung Grace Chen; Rachel Kruzan; Cynthia M Boyd
Journal:  J Am Board Fam Med       Date:  2019 May-Jun       Impact factor: 2.657

5.  Interventions to Optimise Prescribing in Older People with Dementia: A Systematic Review.

Authors:  Leila Shafiee Hanjani; Duncan Long; Nancye M Peel; Geeske Peeters; Christopher R Freeman; Ruth E Hubbard
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

6.  Polypharmacy patterns in the last year of life in patients with dementia.

Authors:  Rachel Denholm; Richard Morris; Rupert Payne
Journal:  Eur J Clin Pharmacol       Date:  2019-07-25       Impact factor: 2.953

7.  How complete is the information on preadmission psychotropic medications in inpatients with dementia? A comparison of hospital medical records with dispensing data.

Authors:  Federica Edith Pisa; Francesca Palese; Federico Romanese; Fabio Barbone; Giancarlo Logroscino; Oliver Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-05       Impact factor: 4.035

8.  Systems Delivery Innovation for Alzheimer Disease.

Authors:  Nicholas T Bott; Clifford C Sheckter; Daniel Yang; Stephanie Peters; Brian Brady; Scooter Plowman; Soo Borson; Bruce Leff; Robert M Kaplan; Terry Platchek; Arnold Milstein
Journal:  Am J Geriatr Psychiatry       Date:  2018-09-28       Impact factor: 4.105

9.  Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

Authors:  François Montastruc; Virginie Gardette; Christelle Cantet; Antoine Piau; Maryse Lapeyre-Mestre; Bruno Vellas; Jean-Louis Montastruc; Sandrine Andrieu
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

10.  Standing on the shoulders of Mark H. Beers: more than a giant in geriatric medicine.

Authors:  Denys T Lau
Journal:  Clin Ther       Date:  2009-04       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.